Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery.
However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics.
Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth.
However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.
Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds.
Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.
This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period.
North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Know More Details About the Report
Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022
As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022.
Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022.
This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Avail customized purchase options for your needs
The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include
- AstraZeneca, plc
- Corden Pharma GmbH
- Ipsen S.A
- Merck & Co.Inc.,
- Pfizer Inc
- Apotex HoldingsInc.,
- Dr. Reddy's Laboratories Limited
- Fresenius Kabi USA LLC
- Novetide Ltd
- Amneal Pharmaceuticals LLC.
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
Global peptide based cardiovascular therapeutics market is exhibiting excellent growth. As the manufacturers are developing new methods for the development of novel peptides that are used in curing of cardiovascular disorders with decreasing cost, this market is showing a positive trajectory.
This Fact.MR report analyzes the expansion of global peptide based cardiovascular therapeutics market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The scope of Fact.MR’s report is to analyze the global peptide based cardiovascular therapeutics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.
Peptide based cardiovascular therapeutics providers, research institutes and key players in the global peptide based cardiovascular therapeutics market can benefit from the analysis offered in this report.
This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide based cardiovascular therapeutics.
The report commences with a brief information of the global peptide based cardiovascular therapeutics market. This executive summary sets the tone for the rest of the report, providing users the scope of the report.
The executive summary includes important facts and statistics on the global peptide based cardiovascular therapeutics market.
The next section offers an overview of the global peptide based cardiovascular therapeutics market. This comprises an introduction to the market, along with a standard definition of the service – peptide based cardiovascular therapeutics.
In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global peptide based cardiovascular therapeutics market, the report provides updates about market opportunities, which can benefit leading service providers of peptide based cardiovascular therapeutics.
With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for peptide based cardiovascular therapeutics market players to formulate key business strategies.
Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of healthcare service providers, and cost structure are provided in this section.
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global peptide based cardiovascular therapeutics market.
Drug type, distribution channel and region are key segments that define the growth of the global market for peptide based cardiovascular therapeutics. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
The report’s last section comprises of the global peptide based cardiovascular therapeutics market competitive landscape, to provide readers with the dashboard view of company analysis and market players.
This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global peptide based cardiovascular therapeutics market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research.
We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.